Drug buyer accuses Celgene of illegally maintaining Thalomid, Revlimid monopoly
MLex Summary: Drug company Celgene has used safety restrictions on the distribution of the drugs Thalomid and Revlimid to stop generic rivals from making their own versions, a health fund said...To view the full article, register now.
Already a subscriber? Click here to view full article